Integrating molecular interactions and gene expression to identify biomarkers to predict response to tumor necrosis factor inhibitor therapies in rheumatoid arthritis patients(1)

BACKGROUND: Targeted therapy using anti-TNF (tumor necrosis factor) is the first option for patients with rheumatoid arthritis (RA). Anti-TNF therapy, however, does not lead to meaningful clinical improvement in many RA patients. To predict which patients will not benefit from anti-TNF therapy, clin...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Min-Fan, Liang, Yong, Huang, Hai-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028654/
https://www.ncbi.nlm.nih.gov/pubmed/35124619
http://dx.doi.org/10.3233/THC-THC228041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028654/
https://www.ncbi.nlm.nih.gov/pubmed/35124619
http://dx.doi.org/10.3233/THC-THC228041

Ejemplares similares